• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    8/28/23 1:54:09 PM ET
    $VTAK
    $WRNT
    $XOMA
    $XXII
    Medical/Dental Instruments
    Health Care
    Other Consumer Services
    Consumer Discretionary
    Get the next $VTAK alert in real time by email

     

    During Monday, 102 stocks hit new 52-week lows.

    Interesting Points From Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was AMC Enter Hldgs (NYSE:AMC).
    • The smallest company by market cap to set a new 52-week low was Aditxt (NASDAQ:ADTX).
    • NovoCure (NASDAQ:NVCR)'s stock traded down the lowest, falling 32.92% to reach a new 52-week low.
    • Allot (NASDAQ:ALLT) saw the sharpest rebound, as shares ascended 0.0%, reversing after hiting a new 52-week low.

    The following stocks set new 52-week lows on Monday:

    • AMC Enter Hldgs (NYSE:AMC) stock drifted down 4.18% on Monday morning to hit a new 52-week low of $11.26.
    • Cracker Barrel Old (NASDAQ:CBRL) stock achieved a new 52-week low on Monday morning, hitting $80.55 and moving up 0.29%.
    • Verve Therapeutics (NASDAQ:VERV) stock drifted down 0.58% on Monday morning to hit a new 52-week low of $12.85.
    • SIGNA Sports United (NYSE:SSU) shares set a new yearly low of $1.26 this morning. The stock was down 6.99% on the session.
    • Scilex Holding (NASDAQ:SCLX) shares made a new 52-week low of $2.82 on Monday. The stock was down 9.42% for the day.
    • IGM Biosciences (NASDAQ:IGMS) shares set a new yearly low of $7.08 this morning. The stock was down 4.38% on the session.
    • Sohu.com (NASDAQ:SOHU) shares made a new 52-week low of $10.40 on Monday. The stock was down 0.85% for the day.
    • Chijet Motor Co (NASDAQ:CJET) shares moved down 0.27% on Monday to hit a new 52-week low of $1.82, drifting down 0.27%.
    • Sharecare (NASDAQ:SHCR) stock dropped to a yearly low on Monday of $0.78. Shares traded down 0.01%.
    • 2seventy bio (NASDAQ:TSVT) stock hit a new 52-week low of $5.25. The stock was down 3.91% on the session.
    • Blink Charging (NASDAQ:BLNK) shares set a new 52-week low of $4.05. The stock traded down 2.97%.
    • PIMCO Municipal Income (NYSE:PMX) shares were down 0.06% for the day, having made a 52-week low of $7.27.
    • XIAO-I (NASDAQ:AIXI) shares reached a new 52-week low of $2.96 on Monday morning, moving down 23.37%.
    • TriSalus Life Sciences (NASDAQ:TLSI) shares were down 3.1% for the day, having made a 52-week low of $6.36.
    • XOMA (NASDAQ:XOMA) stock hit a new 52-week low of $14.62. The stock was down 2.06% on the session.
    • ALX Oncology Holdings (NASDAQ:ALXO) stock hit a new 52-week low of $3.99. The stock was down 4.27% on the session.
    • Benson Hill (NYSE:BHIL) stock broke to a new 52-week low of $0.57 on Monday. Shares of the company traded down 3.56%.
    • LumiraDx (NASDAQ:LMDX) shares set a new 52-week low of $0.31. The stock traded down 12.81%.
    • ADC Therapeutics (NYSE:ADCT) stock set a new 52-week low of $1.20 on Monday, moving down 4.65%.
    • Athira Pharma (NASDAQ:ATHA) shares moved down 2.88% on Monday to hit a new 52-week low of $2.21, drifting down 2.88%.
    • ProPhase Labs (NASDAQ:PRPH) stock achieved a new 52-week low on Monday morning, hitting $5.01 and moving down 3.23%.
    • Allot (NASDAQ:ALLT) shares set a new yearly low of $2.08 this morning. The stock was 0.0% (flat) on the session.
    • Porch Group (NASDAQ:PRCH) shares reached a new 52-week low of $0.76 on Monday morning, moving down 1.94%.
    • Loop Media (AMEX:LPTV) shares reached a new 52-week low of $1.04 on Monday morning, moving down 11.06%.
    • Enthusiast Gaming Hldgs (NASDAQ:EGLX) shares moved down 8.52% on Monday to hit a new 52-week low of $0.37, drifting down 8.52%.
    • Marketwise (NASDAQ:MKTW) shares moved down 2.86% on Monday to hit a new 52-week low of $1.35, drifting down 2.86%.
    • 22nd Century Group (NASDAQ:XXII) shares fell to $1.84 on Monday, setting a new 52-week low with a shift of down 3.14%.
    • China Green Agriculture (NYSE:CGA) stock drifted down 0.4% on Monday morning to hit a new 52-week low of $2.50.
    • Phunware (NASDAQ:PHUN) stock dropped to a yearly low on Monday of $0.25. Shares traded down 10.64%.
    • Mega Matrix (AMEX:MPU) shares were up 0.32% for the day, having made a 52-week low of $0.92.
    • Yoshitsu Co (NASDAQ:TKLF) stock drifted down 2.67% on Monday morning to hit a new 52-week low of $0.76.
    • Pluri (NASDAQ:PLUR) stock hit a new 52-week low of $0.63. The stock was down 3.04% on the session.
    • Aesthetic Medical Intl (NASDAQ:AIH) shares set a new yearly low of $0.61 this morning. The stock was down 5.29% on the session.
    • Alzamend Neuro (NASDAQ:ALZN) shares fell to $0.25 on Monday, setting a new 52-week low with a shift of down 3.89%.
    • Anitra (AMEX:AZTR) stock hit a yearly low of $1.93. The stock was 0.0% (flat) for the day.
    • Earlyworks Co (NASDAQ:ELWS) stock hit a new 52-week low of $1.41. The stock was down 2.65% on the session.
    • CalAmp (NASDAQ:CAMP) shares fell to $0.57 on Monday, setting a new 52-week low with a shift of down 3.65%.
    • Warrantee (NASDAQ:WRNT) shares fell to $0.86 on Monday, setting a new 52-week low with a shift of down 3.54%.
    • Near Intelligence (NASDAQ:NIR) stock hit a new 52-week low of $0.38. The stock was down 3.52% on the session.
    • Brera Holdings (NASDAQ:BREA) shares set a new 52-week low of $1.44. The stock traded down 5.62%.
    • SRM Entertainment (NASDAQ:SRM) shares moved up 1.82% on Monday to hit a new 52-week low of $1.60, drifting up 1.82%.
    • American Strategic (NYSE:NYC) stock hit a yearly low of $6.40. The stock was down 4.3% for the day.
    • Momentus (NASDAQ:MNTS) shares reached a new 52-week low of $7.56 on Monday morning, moving down 7.61%.
    • PolyPid (NASDAQ:PYPD) stock set a new 52-week low of $0.30 on Monday, moving down 5.65%.
    • Yunji (NASDAQ:YJ) shares set a new 52-week low of $0.65. The stock traded up 5.76%.
    • RVL Pharmaceuticals (NASDAQ:RVLP) stock dropped to a yearly low on Monday of $0.12. Shares traded down 4.64%.
    • Cineverse (NASDAQ:CNVS) stock dropped to a yearly low on Monday of $0.97. Shares traded up 1.5%.
    • Multi Ways Holdings (AMEX:MWG) stock hit a new 52-week low of $0.36. The stock was up 5.25% on the session.
    • Sunshine Biopharma (NASDAQ:SBFM) shares reached a new 52-week low of $0.40 on Monday morning, moving down 1.17%.
    • Avalon Globocare (NASDAQ:ALBT) shares moved down 6.8% on Monday to hit a new 52-week low of $0.93, drifting down 6.8%.
    • Organovo Holdings (NASDAQ:ONVO) stock achieved a new 52-week low on Monday morning, hitting $1.14 and moving down 0.3%.
    • AgileThought (NASDAQ:AGIL) stock achieved a new 52-week low on Monday morning, hitting $0.16 and moving down 30.19%.
    • OLB Gr (NASDAQ:OLB) shares fell to $0.56 on Monday, setting a new 52-week low with a shift of down 3.89%.
    • Moving iMage Technologies (AMEX:MITQ) shares made a new 52-week low of $0.85 on Monday. The stock was down 3.39% for the day.
    • iSpecimen (NASDAQ:ISPC) shares reached a new 52-week low of $0.95 on Monday morning, moving down 4.66%.
    • Arcimoto (NASDAQ:FUV) shares set a new 52-week low of $0.98. The stock traded down 2.95%.
    • Aravive (NASDAQ:ARAV) stock dropped to a yearly low on Monday of $0.11. Shares traded down 5.89%.
    • Hempacco (NASDAQ:HPCO) stock set a new 52-week low of $0.30 on Monday, moving down 1.61%.
    • Antelope Ent Hldgs (NASDAQ:AEHL) shares set a new 52-week low of $0.42. The stock traded down 6.26%.
    • Processa Pharma (NASDAQ:PCSA) shares set a new 52-week low of $0.30. The stock traded 0.0% (flat).
    • FOXO Technologies (AMEX:FOXO) stock set a new 52-week low of $0.12 on Monday, moving down 5.3%.
    • Pop Culture Gr (NASDAQ:CPOP) stock drifted down 9.22% on Monday morning to hit a new 52-week low of $0.27.
    • ABVC BioPharma (NASDAQ:ABVC) shares made a new 52-week low of $1.60 on Monday. The stock was down 2.92% for the day.
    • Ontrak (NASDAQ:OTRK) stock set a new 52-week low of $1.30 on Monday, moving down 4.16%.
    • Universe Pharmaceuticals (NASDAQ:UPC) shares made a new 52-week low of $1.36 on Monday. The stock was 0.0% (flat) for the day.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $1.58 on Monday morning, moving down 1.84%.
    • Jeffs Brands (NASDAQ:JFBR) shares fell to $0.50 on Monday, setting a new 52-week low with a shift of down 3.81%.
    • Jiuzi Hldgs (NASDAQ:JZXN) stock set a new 52-week low of $0.98 on Monday, moving down 9.19%.
    • Hallmark Financial Servs (NASDAQ:HALL) shares reached a new 52-week low of $2.02 on Monday morning, moving down 9.02%.
    • SMX (Security Matters) (NASDAQ:SMX) stock hit a new 52-week low of $1.66. The stock was down 2.84% on the session.
    • SINTX Techs (NASDAQ:SINT) stock hit a new 52-week low of $0.85. The stock was down 1.32% on the session.
    • Reshape Lifesciences (NASDAQ:RSLS) shares were down 3.7% for the day, having made a 52-week low of $1.03.
    • Catheter Precision (AMEX:VTAK) shares set a new 52-week low of $0.48. The stock traded down 2.43%.
    • Versus Systems (NASDAQ:VS) shares set a new yearly low of $0.29 this morning. The stock was down 6.39% on the session.
    • BTC Digital (NASDAQ:METX) shares fell to $1.93 on Monday, setting a new 52-week low with a shift of down 12.21%.
    • cbdMD (AMEX:YCBD) shares moved 0.0% (flat) on Monday to hit a new 52-week low of $1.03, drifting 0.0% (flat).
    • SuperCom (NASDAQ:SPCB) shares set a new 52-week low of $0.48. The stock traded down 5.68%.
    • American Rebel Holdings (NASDAQ:AREB) shares hit a yearly low of $0.98. The stock was down 1.0% on the session.
    • Recruiter.Com Group (NASDAQ:RCRT) stock drifted down 6.52% on Monday morning to hit a new 52-week low of $1.67.
    • First Wave BioPharma (NASDAQ:FWBI) stock broke to a new 52-week low of $0.31 on Monday. Shares of the company traded down 1.42%.
    • SenesTech (NASDAQ:SNES) shares set a new 52-week low of $0.60. The stock traded down 5.82%.
    • Aditxt (NASDAQ:ADTX) stock broke to a new 52-week low of $7.47 on Monday. Shares of the company traded down 16.91%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $VTAK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VTAK
    $WRNT
    $XOMA
    $XXII

    CompanyDatePrice TargetRatingAnalyst
    Cineverse Corp.
    $CNVS
    2/19/2026$12.00Speculative Buy → Buy
    The Benchmark Company
    Porch Group Inc.
    $PRCH
    2/11/2026$10.50Mkt Perform → Outperform
    Keefe Bruyette
    Allot Ltd.
    $ALLT
    1/12/2026$15.00Overweight
    Cantor Fitzgerald
    ALX Oncology Holdings Inc.
    $ALXO
    11/13/2025$4.00Buy
    Jefferies
    Allot Ltd.
    $ALLT
    10/23/2025$12.50Buy
    Needham
    Allot Ltd.
    $ALLT
    10/20/2025$13.00Buy
    TD Cowen
    Cracker Barrel Old Country Store Inc
    $CBRL
    10/17/2025$42.00Equal Weight
    Wells Fargo
    CAMP4 Therapeutics Corporation
    $CAMP
    10/2/2025$7.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $VTAK
    $WRNT
    $XOMA
    $XXII
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cineverse upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Cineverse from Speculative Buy to Buy and set a new price target of $12.00

    2/19/26 7:46:51 AM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Porch Group upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Porch Group from Mkt Perform to Outperform and set a new price target of $10.50

    2/11/26 7:42:24 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Cantor Fitzgerald initiated coverage on Allot Comms with a new price target

    Cantor Fitzgerald initiated coverage of Allot Comms with a rating of Overweight and set a new price target of $15.00

    1/12/26 8:11:27 AM ET
    $ALLT
    Computer Communications Equipment
    Telecommunications

    $VTAK
    $WRNT
    $XOMA
    $XXII
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VTAK
    $WRNT
    $XOMA
    $XXII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moyes Jay M bought $2,910 worth of shares (1,000 units at $2.91), increasing direct ownership by 33% to 4,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/25/26 9:00:02 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Mathews Michael

    4 - Avalon GloboCare Corp. (0001630212) (Issuer)

    2/24/26 4:30:28 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Mathews Michael

    3 - Avalon GloboCare Corp. (0001630212) (Issuer)

    2/24/26 4:30:17 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $VTAK
    $WRNT
    $XOMA
    $XXII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moyes Jay M bought $2,910 worth of shares (1,000 units at $2.91), increasing direct ownership by 33% to 4,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/25/26 9:00:02 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Director Gordon Gary B. bought $40,000 worth of shares (9,756 units at $4.10) (SEC Form 4)

    4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)

    2/23/26 4:08:23 PM ET
    $TLSI
    Medical Specialities
    Health Care

    Chief Financial Officer Patience David bought $14,994 worth of shares (3,657 units at $4.10), increasing direct ownership by 1% to 268,657 units (SEC Form 4)

    4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)

    2/23/26 4:08:30 PM ET
    $TLSI
    Medical Specialities
    Health Care

    $VTAK
    $WRNT
    $XOMA
    $XXII
    SEC Filings

    View All

    Azitra Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Azitra, Inc. (0001701478) (Filer)

    2/27/26 5:02:57 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Azitra Inc

    10-K - Azitra, Inc. (0001701478) (Filer)

    2/27/26 5:02:15 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form F-1/A filed by SMX (Security Matters) Public Limited Company

    F-1/A - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/27/26 5:01:28 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    $VTAK
    $WRNT
    $XOMA
    $XXII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

    FREEHOLD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of 6,372,550 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 warrants to purchase up to an aggregate of 6,372,550 shares of common stock and Series A-2 warrants to purchase up to an aggregate of 6,372,550 shares of common stock, at a purchase price of $0.51 per share (or pre-

    2/27/26 5:30:26 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

    BRANFORD, Conn., Feb. 27, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the full year ended December 31, 2025, and provided a business update. FY 2025 and Recent Business HighlightsInitiated Phase 1/2 Trial for ATR-04 program targeting oncology patients with EGFRi-associated rash; presented ATR-04 trial design and update at ASCO 2025Announced positive preclinical data for ATR-01 program, targeting the treatment of ichth

    2/27/26 5:30:00 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Novocure to Participate in 2026 Leerink Global Healthcare Conference

    Novocure (NASDAQ:NVCR) announced today that management will participate in the Leerink Global Healthcare Conference on Tuesday, March 10, 2026. Frank Leonard, Chief Executive Officer, and Christoph Brackmann, Chief Financial Officer, will take part in a fireside chat at 11:20 a.m. EST, as well as one-on-one meetings with investors throughout the event. A live audio webcast of this presentation can be accessed from the Investor Relations page of Novocure's website, www.novocure.com/investor-relations, and will be available for replay for at least 14 days following the event. About Novocure Novocure is a global oncology company working to extend survival in some of the most aggressive for

    2/27/26 4:30:00 PM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    $VTAK
    $WRNT
    $XOMA
    $XXII
    Financials

    Live finance-specific insights

    View All

    ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

    - Clinical development for both the investigational CD47-inhibitor evorpacept and the novel EGFR-targeted antibody-drug conjugate ALX2004 remains on track following strong 2025 execution; company anticipates multiple meaningful data sets and milestones in the coming 12 to 18 months - - Evorpacept biomarker strategy validated by data from both the Phase 2 ASPEN-06 gastric cancer trial and the Phase 1b/2 breast cancer trial, independently suggesting CD47 overexpression is predictive of evorpacept activity and drives durable benefit in HER2-positive cancers - - Full biomarker analysis from Phase 1b/2 evorpacept-zanidatamab combination trial accepted for poster presentation at ESMO Breast Canc

    2/27/26 8:00:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2025

    Fourth quarter operating income increases year-over-year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., announced today its consolidated results for the fiscal fourth quarter and year ended January 1, 2026. "NCM expanded fourth quarter revenue by 8% year-over-year, demonstrating the returns from our continued investment in our platform over the course of the year," said Tom Lesinski, Chief Execu

    2/26/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

    Full year 2025 net revenues of $655 million and fourth quarter net revenues of $174 million Optune Pax® approved by the U.S. FDA for the treatment of locally advanced pancreatic cancer, commercial launch underway Novocure (NASDAQ:NVCR) today reported financial results for the quarter and full year ended December 31, 2025. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields). "In 2025, a record number of patients received treatment with Novocure's Tumor Treating Fields therapy, a milestone that reflects our growth and commitment to advanc

    2/26/26 7:00:00 AM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    $VTAK
    $WRNT
    $XOMA
    $XXII
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Athira Pharma Inc. on Jun 25

    Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

    6/26/24 3:07:15 PM ET
    $ATHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $VTAK
    $WRNT
    $XOMA
    $XXII
    Leadership Updates

    Live Leadership Updates

    View All

    SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

    Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX Technologies, Inc., effective March 16, 2026. Mr. Elmore most recently served as Core Business Director at Invibio, a division of Victrex plc. With more than 15 years of experience in advanced biomaterials and medical dev

    2/18/26 8:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors

    TriSalus Life Sciences, Inc. (NASDAQ:TLSI) ("TriSalus" or the "Company"), an oncology-focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes for patients with solid tumors, today announced changes to its Board of Directors. TriSalus announced that Dr. Arjun "JJ" Desai, a member of the Board since August of 2023, has elected to resign from the Board. The Company and the Board expressed their sincere appreciation for Dr. Desai's service and contributions during his tenure. Concurrently, TriSalus announced that Michael P. Stansky has been appointed to the Company's Board of Directors, effective February 4, 2026

    2/9/26 9:00:00 AM ET
    $TLSI
    Medical Specialities
    Health Care

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $VTAK
    $WRNT
    $XOMA
    $XXII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    12/12/24 7:05:07 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Mega Matrix Inc.

    SC 13D/A - Mega Matrix Inc (0001953021) (Subject)

    12/11/24 5:04:24 PM ET
    $MPU
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form SC 13G filed by TriSalus Life Sciences Inc.

    SC 13G - TriSalus Life Sciences, Inc. (0001826667) (Subject)

    12/4/24 4:00:06 PM ET
    $TLSI
    Medical Specialities
    Health Care